BID and cancer: Combined with the increased sensitivity of the high-risk group to ferroptosis caused by the high expression of BID and TAZ, we speculated that the overexpression of CD44 may play a role in antagonizing TAZ and BID, thereby making cancer cells resistant to lipid peroxidation-mediated ferroptosis.